Mitsubishi Chemical Holdings (JP:4188) has released an update.
Mitsubishi Chemical Group Corporation has denied reports by Nikkei Inc. regarding the early-stage negotiations for the sale of Mitsubishi Tanabe Pharma Corporation, stating there is no such fact. The company affirmed its ongoing review of its business portfolio, including Pharma, and its consideration of all options, including divestiture. Future disclosures will be made as necessary.
For further insights into JP:4188 stock, check out TipRanks’ Stock Analysis page.
